Actualidad

Published on 7 de noviembre de 2022 | http://doi.org/10.5867/medwave.2022.S3.2589

Decline of cytology-based cervical cancer screening for COVID-19: a single-center Peruvian experience

Back to article

Sequence of predicted Pap smears for the 2020 period according to the ARIMA (1,0,0) model. Note the trend in Papaniclolaou smears (cervicovaginal smears) prior to 2020 (blue line) and the forecast for 2020 (red line) without the effect of prevention measures by COVID-19.

Pap, Pananicolaou.

Source: Prepared by the authors of this study.